Skip to content

maison medicale globule

Active
Non-profit associationfounded 2008active for 18 yearsBlauweregenlaan 11, 1030 Schaarbeek, BelgiumKBO/BCE: BE 0896.023.939
Summary

maison medicale globule has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €860,499 and a net result of €89,068. Equity has been growing by about 5.1% per year since 2019. Its solvency ranks better than 94% of 783 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 24-02-2008 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.169.395.892 1030 Schaarbeek, since 24-02-2008
Financial year end
31 December
Peppol
Reachable since 07-10-2025

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€602,837
▲ 6.4%
Turnover
≈ €1.2m
estimated
Surplus
€89,068
▼ 13.7%
Equity
€860,499
▲ 11.5%
Total assets
€917,902
▲ 9.9%
Employees on 31-12-2025
9
=
Score breakdownlowers riskLegal form: non-profit associationLiquidity: current ratio 15.66, cash €749,158Sector: Human health activities (NACE 86)Equity €860,499 (93.7% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 65% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 93.7% of total assets
Liquidity 100=
short-term debt 6.3% · cash 81.6%
Profitability 81-3
return on assets 9.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025highest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €80,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 15.66 (13.13 in 2024), above the usual 1.5. Short-term debt is 6.3% and cash 81.6% of total assets. 6.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 28% on profitability and 54% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Legal form: non-profit association
KBO
lowers risk · Liquidity: current ratio 15.66, cash €749,158
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €860,499 (93.7% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
21 days early
2024
69 days late
2023
119 days late
2022
56 days late
2021
106 days late
2020
158 days late
2019
21 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 73 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 October (4 of the last 5 accounts filed within 51 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 94% of companies in human healthsector median 58.0% · 783 companies 93.7% View

Recent changes

  1. · Gazette deed 2 directors appointed, 2 directors resigning, 3 reappointedResignations: GUNEL Bilen (director) and GRAILET Noémie (director) · Reappointments: TREMOUILLAULT Florence, LIENARD Florent and RANCAN Marco · Appointments: HENROTIN Kimbisikila-Ndie-Awiba (director) and DUCHAMP Anne Laure (director)
  2. · Gazette deed 5 directors appointed, 5 directors resigningResignations: TREMOUILLAULT Florence, OMARI Karima and 3 others · Appointments: TREMOUILLAULT Florence, RANCAN Marco and 3 others
  3. · Gazette deed Amendment of the articles
All 14 events

Comparable companies

These companies have the same main activity as maison medicale globule: general medical practice (NACE 86210). They are comparable in size and age: total assets between €789,000 and €1.6m, founded between 1995 and 2009.

CompanyTotal assetsGross margin
maison medicale globule Schaarbeek€0.9m€0.6m
maison medicale perspective Anderlecht€1.0m€0.5m
Maison Médicale Etoile Santé Ukkel€1.0m€0.7m
MEDICE Rotselaar€1.2m€0.6m
Artsenkring Zennevallei Halle€0.8m€0.5m
l'Aster Schaarbeek€0.8m€0.5m
Maison Médicale Neptune Schaarbeek€1.6m€0.7m
Full comparison

Key facts about maison medicale globule

What is the company number of maison medicale globule?
The company number of maison medicale globule is 0896.023.939. The VAT number is the same number with BE in front: BE 0896.023.939.
Where is maison medicale globule based?
The registered office is at Blauweregenlaan 11, 1030 Schaarbeek.Company details
What does maison medicale globule do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of maison medicale globule?
The legal form of maison medicale globule is Non-profit association (VZW).
When was maison medicale globule founded?
maison medicale globule was founded on 24-02-2008.
Is maison medicale globule still active?
Yes, maison medicale globule is an active enterprise in the KBO register.
How many employees does maison medicale globule have?
maison medicale globule had an average of 6.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of maison medicale globule?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €602,837 and 40 comparable companies (NACE 862). It probably lies between €790,000 and €1.9m.
Is maison medicale globule profitable?
In financial year 2025, maison medicale globule made a profit of €89,068.
Where can I find the annual accounts of maison medicale globule?
maison medicale globule filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of maison medicale globule due?
maison medicale globule must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.